Open AccessMedicineEconomics

J. DiMasi, R. Hansen, H. Grabowski

2003.3.1JOURNAL OF HEALTH ECONOMICS

DOI: 10.1016/s0167-6296(02)00126-1

tlooto Summary

The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms and used to estimate the average pre-tax cost of new drug development.

Abstract

Abstract is not available.

Citation format

DIMASI, J.; HANSEN, R.; GRABOWSKI, H. The price of innovation: New estimates of drug development costs. JOURNAL OF HEALTH ECONOMICS, 2003, 22 2: 151–85.